data_2f2i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f2i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.786 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.786 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.63 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.516 HG22 ' HZ1' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' HZ1' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.453 HG21 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.658 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.808 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.808 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.465 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' HG ' HG21 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG21 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.634 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.768 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.497 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD2' HD11 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.579 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 12' ' ' THR . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.579 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.529 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.499 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.563 ' CG ' ' HZ3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HZ3' ' CG ' ' A' ' 20' ' ' ASP . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.525 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.734 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.734 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.457 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.65 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.613 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.613 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.65 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.52 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.63 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.634 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.812 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.812 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD2' HD12 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 27' ' ' LEU . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.481 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.724 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.724 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.513 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.774 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.774 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.474 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.747 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.747 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.472 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.786 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.786 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.63 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.762 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.762 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.516 HG22 ' HZ1' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' HZ1' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.453 HG21 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.658 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.808 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.808 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.465 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 19' ' ' TRP . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' HG ' HG21 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG21 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.634 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.768 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.497 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD2' HD11 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.724 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.579 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 12' ' ' THR . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.579 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.529 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.499 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' CG ' ' HZ3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HZ3' ' CG ' ' A' ' 20' ' ' ASP . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.525 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.734 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.734 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.625 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.457 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.65 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.613 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.613 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.65 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.52 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.63 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.634 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.634 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.812 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.812 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD12 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD2' HD12 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 27' ' ' LEU . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.481 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.642 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.724 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.724 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.513 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.774 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.774 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.625 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.474 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG22 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.747 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.747 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.472 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.79 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.604 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 28' ' ' PRO . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.702 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HD2' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.641 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.659 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.628 HG23 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.678 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.784 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HD3' HG22 ' A' ' 4' ' ' THR . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 27' ' ' LEU . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.727 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.588 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.727 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 4' ' ' THR . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.744 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.744 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD13 ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 28' ' ' PRO . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD12 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.633 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 28' ' ' PRO . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD2' HD12 ' A' ' 27' ' ' LEU . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.822 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.822 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD2' HD13 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.402 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.655 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.748 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.529 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.484 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.757 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.79 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.79 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 28' ' ' PRO . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 23' ' ' THR . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.79 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.604 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 28' ' ' PRO . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.702 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HD2' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.641 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.659 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.628 HG23 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.678 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.784 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HD3' HG22 ' A' ' 4' ' ' THR . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 27' ' ' LEU . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.727 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.588 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.727 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 4' ' ' THR . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.744 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.744 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD13 ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 28' ' ' PRO . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD12 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.633 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 28' ' ' PRO . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD2' HD12 ' A' ' 27' ' ' LEU . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.822 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.822 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD2' HD13 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.402 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.655 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.748 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.529 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.484 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.757 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.79 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.79 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 28' ' ' PRO . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 23' ' ' THR . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.79 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.604 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 28' ' ' PRO . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.702 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HD2' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.641 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.659 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.628 HG23 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.678 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.784 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HD3' HG22 ' A' ' 4' ' ' THR . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 27' ' ' LEU . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.727 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.588 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.727 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 4' ' ' THR . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.744 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.744 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD13 ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 28' ' ' PRO . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD12 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.633 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 28' ' ' PRO . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD2' HD12 ' A' ' 27' ' ' LEU . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.822 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.822 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD2' HD13 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.402 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.655 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.748 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.529 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.484 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.757 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.79 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.79 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 28' ' ' PRO . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 23' ' ' THR . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 6.2 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.2 0.524 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.9 3.27 55.14 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.093 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 92.0 mt-10 -65.22 -179.11 0.54 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.724 0.774 . . . . 0.0 111.876 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 3.9 p -133.34 152.54 51.93 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.904 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.08 137.65 47.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.291 0.567 . . . . 0.0 111.78 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -92.54 65.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.295 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.74 -16.42 31.11 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.41 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 146.58 4.02 0.48 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.839 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -89.28 117.44 28.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.7 m -109.67 155.21 21.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.85 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -88.03 -60.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.548 0.213 . . . . 0.0 111.213 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 32.6 m -71.87 118.75 69.56 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.464 0.649 . . . . 0.0 111.511 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.58 121.2 9.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.491 2.127 . . . . 0.0 110.98 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.62 -13.83 13.22 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 67.7 m -88.84 119.24 29.16 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.97 132.09 35.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.874 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.79 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.1 t -78.89 127.4 31.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.006 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.3 m -151.87 126.62 9.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.992 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.4 m95 55.66 43.61 27.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 110.678 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 59.67 22.05 10.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 19.8 mtpp -138.25 143.33 40.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.9 m -93.8 122.32 36.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.424 0.631 . . . . 0.0 111.902 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.5 p -109.19 170.23 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.927 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 31.7 ttt180 -150.9 138.19 19.4 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 60.01 23.15 12.3 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.564 0.54 . . . . 0.0 111.104 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.63 19.56 61.61 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.649 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -154.81 153.52 27.66 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 117.455 0.627 . . . . 0.0 110.419 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.32 74.96 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.092 2.528 . . . . 0.0 113.393 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.604 HG23 ' HG ' ' A' ' 27' ' ' LEU . 57.6 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.778 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 13.0 m . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.01 0.433 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.7 -31.53 3.01 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.422 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 53.3 mm-40 -54.14 171.53 0.11 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.46 1.124 . . . . 0.0 112.996 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 13.0 p -130.29 154.23 47.84 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.846 -1.524 . . . . 0.0 109.978 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -109.76 134.42 52.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.1 t -83.4 62.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.9 2.58 57.16 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.555 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 142.62 -16.76 2.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.628 -1.272 . . . . 0.0 113.712 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -88.07 119.76 28.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.69 136.66 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.693 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.59 -54.1 10.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.773 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -67.86 118.58 59.41 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-O 121.29 0.566 . . . . 0.0 111.755 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.58 130.21 34.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.718 2.279 . . . . 0.0 111.912 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.44 -10.37 65.02 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 76.8 m -89.39 120.41 30.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 0.0 110.017 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.22 138.33 31.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.563 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 44.5 t -77.99 127.93 33.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.206 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.6 p -151.49 122.11 7.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.737 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.8 t90 55.39 46.03 24.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.439 0.638 . . . . 0.0 110.441 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.76 17.58 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.822 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 8.7 ptmm? -139.89 145.91 38.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.131 0.491 . . . . 0.0 110.237 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 12.9 m -88.59 132.72 34.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.465 0.65 . . . . 0.0 112.443 -177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 28' ' ' PRO . 66.5 p -134.9 163.56 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.127 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -137.9 130.91 30.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 57.93 32.38 21.87 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.65 0.594 . . . . 0.0 110.277 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 25.14 76.21 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.753 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 24.4 tp -136.85 130.8 17.81 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 110.386 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.1 Cg_exo -74.29 69.7 4.88 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.368 2.712 . . . . 0.0 112.462 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.735 -179.515 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 20.4 m . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.36 -25.06 3.34 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.442 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.1 -179.14 0.07 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.307 1.051 . . . . 0.0 113.405 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 21' ' ' LYS . 13.5 p -130.08 153.14 48.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.06 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.13 138.42 42.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.163 0.506 . . . . 0.0 111.488 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.33 65.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.794 0.807 . . . . 0.0 109.186 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.83 27.4 41.86 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.641 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.36 -14.58 10.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.292 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 p -89.69 117.07 28.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.2 m -108.87 131.1 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.816 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -71.36 -37.01 71.69 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.702 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -78.66 115.22 50.08 Favored Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 120.99 0.424 . . . . 0.0 111.054 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.61 125.79 18.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.576 2.184 . . . . 0.0 111.834 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.25 -13.37 55.19 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.727 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 65.7 m -90.1 116.04 27.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -89.93 139.59 30.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.393 0.616 . . . . 0.0 110.602 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.4 t -76.92 126.3 30.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.822 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.6 m -151.34 120.19 6.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.052 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.2 t90 57.49 43.26 23.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.445 0.641 . . . . 0.0 109.896 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 59.88 16.68 5.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.251 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HD2' HG22 ' A' ' 4' ' ' THR . 30.6 mmmt -125.56 142.51 51.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -91.17 117.61 29.76 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.336 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.6 p -100.75 158.52 15.9 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.641 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 16.8 tpp180 -126.88 121.53 32.07 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.723 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m120 56.42 28.67 13.98 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.563 0.539 . . . . 0.0 112.208 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.23 4.38 66.58 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.477 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -139.68 144.59 39.75 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 117.928 0.864 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.7 70.45 0.24 Allowed 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.637 2.891 . . . . 0.0 114.223 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 24' ' ' ARG . 58.1 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.043 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.767 0.317 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.94 -35.57 2.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.723 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -56.83 166.21 1.03 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.882 0.849 . . . . 0.0 111.84 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 21' ' ' LYS . 40.6 p -116.86 151.43 36.58 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.236 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.09 140.12 30.47 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.304 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.46 65.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.908 0.861 . . . . 0.0 109.333 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.61 26.76 45.23 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.659 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.02 -15.29 8.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.244 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 p -89.51 117.99 28.82 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 77.1 m -109.87 128.7 55.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -75.51 -46.33 32.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.982 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -64.85 120.17 64.2 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.653 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.03 132.71 48.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.825 2.35 . . . . 0.0 112.711 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.84 -4.32 85.74 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.626 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 50.1 m -93.0 122.12 35.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.358 0.599 . . . . 0.0 110.703 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.6 35.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.659 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 53.7 t -76.45 126.42 30.95 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 m -150.84 122.66 8.1 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 13.0 m95 55.62 39.82 30.96 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.435 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 64.1 m-20 61.14 27.23 17.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.446 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.1 mmtm -136.01 140.71 44.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.9 m -91.76 113.2 25.4 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.472 0.653 . . . . 0.0 111.169 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.6 p -99.59 165.81 11.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.6 ttp180 -150.21 134.05 16.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 59.81 27.15 16.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.465 0.65 . . . . 0.0 110.383 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.98 15.82 71.55 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.812 -0.631 . . . . 0.0 114.319 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.6 pt? -153.14 150.98 25.11 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 118.046 0.923 . . . . 0.0 110.777 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 18.6 Cg_exo -67.13 73.64 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.43 2.753 . . . . 0.0 113.488 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.628 HG23 ' HG ' ' A' ' 27' ' ' LEU . 48.7 t . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.381 0.61 . . . . 0.0 110.137 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.16 -35.17 3.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 17.4 mm-40 -55.97 163.05 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.935 0.874 . . . . 0.0 111.792 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.678 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.5 p -113.25 152.57 29.64 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.028 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -99.04 137.92 36.88 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.13 64.18 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.855 0.836 . . . . 0.0 109.605 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.94 61.06 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.73 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.89 -16.89 5.26 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.291 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.75 118.88 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.2 m -110.29 124.54 51.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.302 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -70.52 -41.56 72.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.308 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.784 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -73.52 118.11 66.21 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-O 121.376 0.607 . . . . 0.0 111.201 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.38 132.2 42.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.656 2.238 . . . . 0.0 112.306 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.8 -10.34 72.43 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.224 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.784 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 55.5 m -89.87 116.2 27.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.2 132.08 35.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.511 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 54.1 t -74.35 125.41 28.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.909 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -151.04 123.73 8.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 t90 58.67 38.1 25.11 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.283 0.563 . . . . 0.0 110.184 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.15 8.34 6.11 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.937 0.875 . . . . 0.0 111.496 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.678 ' HD3' HG22 ' A' ' 4' ' ' THR . 34.7 mmtm -119.1 142.15 48.15 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.719 -0.613 . . . . 0.0 109.883 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.4 m -89.95 106.32 18.4 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 111.002 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.4 p -96.23 164.26 12.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.93 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.487 ' O ' HD13 ' A' ' 27' ' ' LEU . 51.7 ttp85 -150.6 137.84 19.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 59.39 30.81 20.56 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.587 0.708 . . . . 0.0 110.534 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.66 9.88 84.04 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 115.031 0.773 . . . . 0.0 115.031 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -157.73 155.76 27.42 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 118.704 1.252 . . . . 0.0 111.07 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 27' ' ' LEU . 29.6 Cg_endo -64.14 79.68 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.197 2.598 . . . . 0.0 114.343 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.425 0.631 . . . . 0.0 109.414 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.04 -37.04 2.14 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.926 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.3 mm-40 -56.5 170.48 0.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.333 1.063 . . . . 0.0 112.466 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 21' ' ' LYS . 35.1 p -125.0 152.67 43.93 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.469 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.94 137.73 36.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.737 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 t -82.68 65.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.804 0.811 . . . . 0.0 109.318 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.06 41.25 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.291 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.606 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 121.55 -16.4 9.05 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.394 -0.908 . . . . 0.0 113.275 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.35 117.29 28.18 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 63.5 m -108.35 130.91 55.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.43 -49.99 43.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.953 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.781 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -65.36 116.19 28.66 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-O 121.212 0.53 . . . . 0.0 111.449 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 39.3 Cg_exo -59.95 128.73 27.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.627 2.218 . . . . 0.0 112.169 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.53 64.42 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.195 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.781 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.9 m -90.52 117.15 28.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.344 0.592 . . . . 0.0 110.41 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -90.03 132.35 35.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.982 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.606 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 50.6 t -73.06 124.63 25.9 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.854 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 t -150.98 121.33 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.509 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 10.8 t-105 57.98 38.91 26.89 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.566 0.698 . . . . 0.0 109.575 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 63.86 12.3 6.65 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.996 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.88 139.82 49.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.2 m -89.54 96.15 10.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.576 0.703 . . . . 0.0 110.225 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 43.4 p -89.89 159.22 17.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.841 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -149.27 137.64 20.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 56.84 32.02 20.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.06 27.73 69.77 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.15 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD12 ' HD2' ' A' ' 28' ' ' PRO . 19.7 tp -154.38 135.16 8.52 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 117.044 0.422 . . . . 0.0 110.535 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.577 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.8 Cg_endo -72.43 68.14 3.54 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.762 2.308 . . . . 0.0 112.084 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.804 -178.832 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.46 23.52 64.82 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.159 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 38.1 mt-10 -81.38 175.92 10.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.015 0.436 . . . . 0.0 110.936 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 1.0 OUTLIER -112.91 160.29 18.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -135.29 128.32 31.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.04 0.924 . . . . 0.0 113.029 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -86.31 67.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.622 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.7 27.4 12.88 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.059 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.727 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 99.75 6.21 54.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.08 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -89.6 116.23 27.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -113.12 146.01 39.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.73 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -78.16 -55.45 5.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.588 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 3.7 m -75.14 123.38 88.79 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-O 121.324 0.583 . . . . 0.0 112.141 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.41 128.33 24.55 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.233 1.956 . . . . 0.0 110.744 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.78 34.66 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.045 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.3 m -89.41 115.32 26.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 2.0 m -95.16 133.86 38.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.112 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.727 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.3 t -71.52 125.56 27.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.522 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.6 p -150.3 117.98 6.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.274 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 56.75 42.56 26.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.528 0.68 . . . . 0.0 110.366 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' THR . 29.3 t70 64.07 19.37 11.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.269 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 27.3 mmtm -133.24 133.9 43.28 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 41.2 m -88.76 116.0 26.71 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.436 0.636 . . . . 0.0 110.76 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 p -102.86 161.92 13.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -135.46 124.79 24.72 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 56.38 36.43 27.5 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.52 0.513 . . . . 0.0 110.818 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.28 23.46 77.34 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.789 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -138.94 128.97 14.66 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 27' ' ' LEU . 14.4 Cg_exo -69.17 70.19 1.28 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.156 2.571 . . . . 0.0 112.716 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.423 -179.716 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.887 0.375 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.87 -33.56 1.68 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.849 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 4.0 pt-20 -61.75 170.86 1.8 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 122.214 1.007 . . . . 0.0 112.92 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 21' ' ' LYS . 32.7 p -118.92 150.05 40.55 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.544 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -93.22 136.94 33.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.701 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 t -79.73 64.08 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.915 0.864 . . . . 0.0 109.591 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.08 23.74 50.91 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.315 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 124.49 -15.02 7.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.811 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -91.57 117.94 30.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -100.41 149.76 23.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.844 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -79.93 -54.95 5.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.333 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.54 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 19.0 m -75.54 118.26 69.56 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 111.205 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.48 120.51 8.19 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.148 1.899 . . . . 0.0 111.109 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.55 -14.49 11.79 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.051 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.7 m -89.65 121.68 32.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 138.18 31.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.691 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -80.85 123.22 28.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.289 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 19' ' ' TRP . 28.5 m -150.63 122.09 7.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 9.5 m-90 57.56 41.91 25.01 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.59 7.25 0.98 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.309 1.444 . . . . 0.0 112.539 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 4' ' ' THR . 41.2 mmtm -111.82 141.54 45.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 62.7 m -94.49 116.13 28.42 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.412 0.625 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 p -106.51 168.62 9.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.898 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.0 ttt180 -148.19 130.64 15.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 59.93 31.54 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.557 0.536 . . . . 0.0 110.118 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.78 22.68 76.96 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.739 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.1 mt -138.97 143.77 38.52 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.525 0.202 . . . . 0.0 110.646 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 4.3 Cg_exo -73.9 66.85 4.96 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 123.179 2.586 . . . . 0.0 111.561 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.073 -178.767 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.153 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.78 -38.49 2.34 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.674 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 5.5 mm-40 -56.84 168.81 0.57 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.76 0.791 . . . . 0.0 111.655 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 37.3 p -124.3 149.79 46.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.874 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -90.57 139.03 31.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.849 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -82.47 64.51 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.821 0.819 . . . . 0.0 109.526 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.03 47.25 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.424 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.77 -16.88 7.79 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.415 -0.898 . . . . 0.0 113.128 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.8 118.61 29.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -104.78 129.9 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -73.75 -38.06 64.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.135 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.744 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -76.49 117.93 67.94 Favored Pre-proline 0 C--O 1.238 0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.78 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.94 129.28 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.604 2.202 . . . . 0.0 112.274 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.11 -8.66 72.87 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.296 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.744 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.2 m -90.13 122.71 33.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 110.8 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.42 139.23 30.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 42.3 t -79.54 125.1 29.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.565 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.6 m -151.41 134.83 16.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.8 p90 44.67 47.21 8.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.33 0.652 . . . . 0.0 112.079 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.82 32.38 21.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.279 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 55.5 mttm -149.34 150.27 32.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.6 m -95.61 126.46 40.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.305 0.574 . . . . 0.0 111.006 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.2 p -122.66 164.68 17.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.344 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -146.49 139.98 25.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 58.96 29.79 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.612 0.57 . . . . 0.0 110.126 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.57 74.54 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.512 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 97.0 mt -142.1 140.11 18.99 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.806 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.8 Cg_exo -75.1 63.13 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.373 2.716 . . . . 0.0 111.756 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.321 -0.674 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.111 -178.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.208 0.528 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.05 20.48 66.97 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.054 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 69.6 mt-10 -76.54 174.63 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.05 0.452 . . . . 0.0 110.935 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ASP . 19.1 p -109.85 155.31 21.84 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.286 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -127.47 127.62 44.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.95 0.881 . . . . 0.0 112.749 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.93 67.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.48 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.32 27.96 16.41 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.682 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 102.39 3.03 50.75 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.134 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -89.42 116.9 27.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.887 0.375 . . . . 0.0 111.923 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.7 m -112.1 149.72 31.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.015 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -78.67 -59.92 2.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.684 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 46.7 m -71.77 119.86 76.66 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-O 121.449 0.642 . . . . 0.0 111.822 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.3 Cg_exo -61.67 122.75 11.49 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.59 2.193 . . . . 0.0 110.842 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.4 -18.56 13.52 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.3 m -89.11 111.69 22.5 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.4 t -90.48 138.35 31.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.424 0.63 . . . . 0.0 110.463 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 28.9 t -76.05 124.94 28.21 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.797 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.6 m -150.75 118.19 6.06 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 59.62 39.64 21.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.76 0.79 . . . . 0.0 109.445 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 4' ' ' THR . 25.8 t70 67.07 2.73 2.85 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.667 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.63 134.38 53.24 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.716 -0.615 . . . . 0.0 109.85 178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 57.0 m -90.58 120.66 31.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.974 0.416 . . . . 0.0 109.947 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -113.33 156.26 23.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.289 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 24' ' ' ARG . 2.2 tmt_? -111.81 114.23 27.07 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.33 35.11 24.63 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 110.127 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.91 14.53 82.51 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -120.89 125.83 26.9 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD2' HD13 ' A' ' 27' ' ' LEU . 16.4 Cg_exo -68.18 67.49 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.293 2.662 . . . . 0.0 113.196 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.945 179.602 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.68 -27.78 1.87 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.117 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 7.7 pt-20 -64.76 -176.1 0.23 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.173 0.987 . . . . 0.0 113.131 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.9 p -129.41 150.17 50.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.347 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -95.03 137.54 33.94 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.148 0.499 . . . . 0.0 111.6 179.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.61 65.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.9 0.857 . . . . 0.0 109.485 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.8 38.77 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.189 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 119.01 -14.54 11.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.137 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 p -89.93 118.33 29.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.9 m -102.87 146.71 27.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.444 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.33 -51.34 9.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.128 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.44 120.12 80.29 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-O 121.528 0.68 . . . . 0.0 111.4 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 18.6 Cg_endo -59.2 132.08 44.85 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.484 2.123 . . . . 0.0 111.229 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -10.12 61.72 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.966 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.9 m -89.3 119.97 30.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.374 0.607 . . . . 0.0 110.01 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 p -89.23 134.49 34.02 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.767 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -80.94 123.52 28.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.734 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -151.74 129.38 11.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 57.42 41.07 26.8 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 109.96 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 59.57 18.88 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.585 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 mtpt -132.84 147.19 52.3 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 37.6 m -96.12 127.09 41.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.402 0.62 . . . . 0.0 111.079 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 28' ' ' PRO . 30.9 p -133.56 167.98 19.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.282 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.14 115.19 20.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 t30 59.82 36.12 22.02 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.759 0.79 . . . . 0.0 109.714 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.29 9.41 81.05 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD12 ' HD2' ' A' ' 28' ' ' PRO . 24.0 tp -109.08 127.93 26.36 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD2' HD12 ' A' ' 27' ' ' LEU . 58.3 Cg_endo -72.19 67.52 3.4 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.12 2.547 . . . . 0.0 112.973 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.194 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.069 0.461 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.11 42.1 99.72 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.56 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.7 pt-20 -134.73 -178.55 5.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.59 0.71 . . . . 0.0 111.616 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 36.6 p -127.36 149.7 49.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.393 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -96.68 139.05 33.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.535 179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 t -81.89 65.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.816 0.817 . . . . 0.0 109.375 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.02 26.01 50.4 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.512 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.633 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 123.12 -14.48 8.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.39 -0.909 . . . . 0.0 113.287 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -89.74 118.63 29.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 91.7 m -102.6 144.42 31.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.7 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -75.35 -54.25 7.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.119 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 8.8 m -76.17 118.04 68.45 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-O 121.338 0.589 . . . . 0.0 111.388 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 24.2 Cg_exo -61.45 120.84 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.488 2.125 . . . . 0.0 111.28 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.32 -11.73 23.98 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.317 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 71.4 m -89.16 124.63 34.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.095 0.474 . . . . 0.0 109.736 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -89.72 139.0 31.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.616 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.633 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 36.6 t -85.65 124.16 31.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.243 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.8 m -151.2 127.35 10.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.2 t90 54.9 44.95 27.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.11 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 58.51 24.02 11.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.874 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 44.9 mtmt -139.16 147.44 41.86 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -102.39 131.95 48.7 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.352 0.596 . . . . 0.0 111.579 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.2 p -127.28 161.59 28.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.653 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -125.65 125.11 42.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.36 34.26 24.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.422 0.629 . . . . 0.0 110.45 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.16 23.64 77.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.781 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 ' HD2' ' A' ' 28' ' ' PRO . 22.3 tp -136.11 134.64 20.36 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD2' HD12 ' A' ' 27' ' ' LEU . 55.7 Cg_endo -70.57 68.01 2.18 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.947 2.431 . . . . 0.0 112.518 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.445 -179.511 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 8.2 m . . . . . 0 C--O 1.225 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.56 -34.68 2.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.631 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -57.61 168.74 0.79 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.09 0.947 . . . . 0.0 112.174 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 19.3 p -123.27 153.96 39.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.975 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -98.37 136.76 38.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.2 0.524 . . . . 0.0 111.763 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.26 65.66 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.847 . . . . 0.0 109.399 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 26.45 35.88 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.541 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.608 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 118.07 -12.56 12.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.244 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.51 118.78 29.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 77.3 m -108.62 134.0 51.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.915 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -73.5 -51.17 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.928 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.822 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.88 120.1 68.9 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.87 128.71 26.37 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.695 2.263 . . . . 0.0 112.5 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.87 73.37 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.261 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.822 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 82.9 m -89.35 118.78 29.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.061 0.458 . . . . 0.0 109.919 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -89.81 140.4 29.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.608 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.3 t -80.28 121.63 25.88 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.211 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 m -151.26 132.37 14.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.854 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 21.0 m95 53.96 42.4 31.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.761 0.315 . . . . 0.0 111.228 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 27.92 17.72 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.511 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 11.7 pttm -151.76 147.18 26.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.256 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.2 m -89.86 126.96 35.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.233 0.54 . . . . 0.0 111.792 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 47.2 p -114.22 156.32 24.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.711 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 16.9 tpt85 -118.48 119.8 35.64 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 57.13 35.24 26.03 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.525 0.515 . . . . 0.0 110.714 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.87 19.88 79.72 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.093 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD13 ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -135.31 130.03 18.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD2' HD13 ' A' ' 27' ' ' LEU . 20.0 Cg_exo -66.55 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.262 2.641 . . . . 0.0 113.251 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.662 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 62.9 m . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.725 0.297 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.44 -35.19 2.22 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.533 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 15.4 mm-40 -57.67 171.56 0.45 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.848 0.833 . . . . 0.0 111.88 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 4.9 p -126.79 154.11 44.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.941 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -100.19 141.12 33.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.169 179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.53 65.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.703 0.763 . . . . 0.0 109.155 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.73 24.72 61.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.581 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.9 -19.9 4.89 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.243 -0.979 . . . . 0.0 113.727 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.0 OUTLIER -91.1 117.61 29.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.34 131.44 47.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -73.45 -42.03 62.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.343 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.642 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 m -77.67 116.3 57.0 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-O 121.252 0.548 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.13 125.45 17.61 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.623 2.215 . . . . 0.0 112.089 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.17 53.12 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.875 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 77.3 m -93.37 123.84 36.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.294 0.568 . . . . 0.0 110.698 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 p -89.62 134.58 34.07 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.09 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 52.4 t -78.07 127.87 32.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.404 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 m -150.81 121.53 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.258 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 56.34 42.92 27.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t70 60.37 21.12 10.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.24 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 41.0 mtmt -132.66 146.83 52.19 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 39.3 m -95.55 123.35 39.06 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.727 0.775 . . . . 0.0 112.208 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.2 p -113.19 176.66 4.93 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.731 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.402 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 27.5 ttt180 -150.16 126.93 11.0 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 59.88 29.36 18.93 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.784 0.677 . . . . 0.0 110.552 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.53 16.44 80.73 Favored Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.961 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 27' ' ' LEU . 2.8 mm? -131.77 141.9 43.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.738 0.269 . . . . 0.0 110.373 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.23 64.79 5.33 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.751 2.301 . . . . 0.0 111.922 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.137 -178.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 60.0 m . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 120.623 0.249 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.15 -36.91 2.37 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.205 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -57.84 173.12 0.33 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.87 0.843 . . . . 0.0 112.25 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.0 p -125.21 154.44 41.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.956 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -97.79 138.39 35.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.176 0.513 . . . . 0.0 111.722 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.95 63.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.817 0.818 . . . . 0.0 109.749 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.65 22.32 53.8 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.604 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.655 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.58 -15.83 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.929 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -90.2 119.06 30.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 76.4 m -109.42 124.69 51.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.932 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -44.21 64.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.582 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.736 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -66.86 116.07 31.47 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-O 121.292 0.568 . . . . 0.0 111.557 -179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 32.6 Cg_exo -58.97 132.42 47.37 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.648 2.232 . . . . 0.0 111.917 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.2 -2.54 78.88 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.415 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.736 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 57.6 m -98.95 120.86 40.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.414 0.626 . . . . 0.0 110.983 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 p -93.26 135.72 34.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.862 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.655 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 51.0 t -75.34 120.73 21.2 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.282 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.8 m -151.48 128.94 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.84 52.66 12.6 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.113 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 49.27 22.6 0.69 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.305 . . . . 0.0 112.927 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 32.4 mttp -139.58 150.04 44.56 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 55.3 m -91.5 120.21 32.12 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.357 0.599 . . . . 0.0 110.96 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.1 p -112.73 175.23 5.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.526 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -146.5 123.12 11.14 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.24 36.38 23.71 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.612 0.72 . . . . 0.0 109.765 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.25 72.5 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.053 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.6 mt -127.25 138.11 32.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.675 -0.309 . . . . 0.0 110.693 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.41 64.6 5.49 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.971 2.448 . . . . 0.0 112.027 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.126 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.227 -0.119 0 CA-C-O 120.741 0.305 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.04 -39.48 2.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.127 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -57.09 168.91 0.61 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.953 0.883 . . . . 0.0 112.036 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 38.4 p -122.26 151.82 40.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.904 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -97.01 142.03 29.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.5 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 t -82.22 64.36 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.722 0.772 . . . . 0.0 109.441 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.07 24.05 58.23 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.677 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 130.02 -18.82 5.28 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.57 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -89.65 118.76 29.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 59.0 m -107.74 125.98 52.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -68.68 -42.72 77.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.796 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.748 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -73.33 115.47 41.45 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.991 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 133.05 51.85 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.29 83.34 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.629 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.748 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 81.2 m -91.84 122.46 34.4 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.416 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.562 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.2 t -79.2 126.95 31.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.855 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -150.96 126.73 10.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.958 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.529 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 14.9 m95 54.71 38.95 30.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.916 0.389 . . . . 0.0 110.723 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 62.38 29.08 17.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.614 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.0 mttm -141.37 141.35 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.5 m -90.28 126.97 36.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.43 0.633 . . . . 0.0 111.278 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 p -121.62 163.45 18.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.315 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -123.16 116.71 23.89 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 m120 59.58 34.0 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.651 0.594 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.27 85.97 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.015 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.04 139.07 25.38 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.775 0.288 . . . . 0.0 110.385 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.17 61.27 3.26 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.85 2.367 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.981 -179.421 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 29.7 m . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 -31.49 2.52 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.727 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -57.54 175.08 0.19 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.236 1.017 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 21.6 p -129.48 153.18 48.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.252 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -99.69 137.36 38.28 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.793 -179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.3 65.02 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.892 0.853 . . . . 0.0 109.348 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.0 43.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.559 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.626 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 122.22 -15.6 8.75 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.569 -0.825 . . . . 0.0 113.008 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.4 p -89.63 117.98 28.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.6 m -105.93 130.13 53.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.218 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -72.43 -35.09 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.344 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.782 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.97 118.37 72.1 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 111.191 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.86 127.87 22.7 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.405 2.07 . . . . 0.0 111.731 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 -6.85 64.07 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.175 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.782 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 68.5 m -93.3 120.81 34.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.197 0.522 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -90.85 134.92 34.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.062 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 40.7 t -76.11 120.76 21.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.237 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.8 m -151.21 129.99 12.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.69 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' A' ' 19' ' ' TRP . 6.9 t-105 53.28 47.84 23.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 0.0 110.968 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 59.17 20.86 8.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.819 0.848 . . . . 0.0 112.301 179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 20' ' ' ASP . 9.9 mttp -143.11 150.96 40.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.8 m -93.7 122.05 35.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.288 0.565 . . . . 0.0 111.358 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.2 p -110.55 159.85 17.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.634 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.5 ttt85 -127.06 121.87 32.75 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.81 33.33 22.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.581 0.551 . . . . 0.0 110.806 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.48 15.1 81.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.242 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 95.8 mt -128.08 140.38 38.08 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.865 0.333 . . . . 0.0 110.236 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.8 Cg_exo -72.09 62.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.13 2.553 . . . . 0.0 112.172 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.348 -179.018 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.201 0.524 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.61 19.33 74.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.026 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 93.7 mt-10 -86.52 179.47 6.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.509 0.671 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 22.7 p -130.59 149.09 52.41 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.395 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -107.06 135.74 48.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.267 0.556 . . . . 0.0 111.987 -179.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.73 66.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.221 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 26.88 31.64 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 115.62 -10.28 19.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.249 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.9 p -89.17 118.31 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 72.8 m -107.74 146.58 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.394 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -77.48 -59.39 2.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.11 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.484 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 94.3 m -73.87 121.34 84.95 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-O 121.467 0.651 . . . . 0.0 111.877 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 27.2 Cg_exo -60.4 124.76 15.8 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.65 2.233 . . . . 0.0 111.091 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.59 -17.49 23.28 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 48.7 m -89.29 114.52 25.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -91.11 140.87 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 39.1 t -77.71 121.57 24.19 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.56 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -151.82 131.7 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.566 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.3 m95 54.01 44.16 29.73 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.398 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.86 23.85 13.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.436 0.694 . . . . 0.0 112.367 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 22.1 mtmm -146.75 155.21 42.21 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 110.047 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 58.0 m -95.84 119.42 34.3 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.3 0.572 . . . . 0.0 111.469 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 p -106.92 159.23 16.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.387 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.2 tmm_? -131.66 123.65 28.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 58.43 33.25 22.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.355 0.597 . . . . 0.0 110.99 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.56 85.14 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.625 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' HG23 ' A' ' 29' ' ' VAL . 1.3 pt? -141.95 141.53 22.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 118.237 1.018 . . . . 0.0 110.947 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 21.7 Cg_exo -65.91 75.82 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.552 2.835 . . . . 0.0 113.63 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 27' ' ' LEU . 46.8 t . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.243 0.544 . . . . 0.0 109.689 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 29.4 m . . . . . 0 CA--C 1.521 -0.166 0 CA-C-O 120.916 0.389 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.15 -35.56 1.95 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.181 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -55.34 174.07 0.1 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.052 0.93 . . . . 0.0 112.969 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 24.5 p -124.78 152.97 43.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.805 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -101.46 140.54 35.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.173 0.511 . . . . 0.0 111.614 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.7 t -81.33 64.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.821 0.82 . . . . 0.0 109.518 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.32 25.44 54.65 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.54 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.651 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 126.19 -16.8 6.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.447 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -89.58 118.99 29.62 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 68.1 m -108.65 127.45 53.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.38 -42.85 67.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.064 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.757 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -71.38 117.07 53.61 Favored Pre-proline 0 C--O 1.239 0.528 0 CA-C-O 121.207 0.527 . . . . 0.0 111.005 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.9 129.3 31.39 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.794 2.33 . . . . 0.0 112.87 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.12 -6.45 78.76 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.44 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.757 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 83.7 m -89.48 121.67 31.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.451 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.33 136.87 32.78 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.241 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 41.6 t -77.42 125.49 29.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.982 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.9 p -150.87 121.29 7.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.721 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.0 t90 57.57 43.49 22.53 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.519 0.676 . . . . 0.0 109.831 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.7 14.61 5.16 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.385 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 30.2 mtpt -128.7 144.49 51.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.0 m -91.44 126.85 36.66 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.378 0.608 . . . . 0.0 111.682 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.9 p -115.75 159.04 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -112.39 107.45 16.25 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t30 61.57 35.49 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.72 . . . . 0.0 109.477 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.77 89.4 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.8 mt -107.58 135.59 19.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 117.246 0.523 . . . . 0.0 110.1 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.07 59.31 2.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.753 2.302 . . . . 0.0 112.579 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.917 -179.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 11.0 m . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.54 -33.73 2.98 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.774 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -56.68 173.93 0.17 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.283 1.04 . . . . 0.0 112.701 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 31.1 p -127.13 151.72 48.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.186 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -98.63 139.43 34.35 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.675 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.79 65.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.855 0.836 . . . . 0.0 109.323 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.29 27.17 40.88 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.366 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 120.72 -15.27 9.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.361 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.3 p -89.44 118.28 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.4 m -108.36 130.44 55.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -74.32 -34.33 63.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.79 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -79.45 118.66 73.67 Favored Pre-proline 0 C--O 1.24 0.561 0 CA-C-O 121.267 0.556 . . . . 0.0 111.034 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.72 134.01 54.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.611 2.207 . . . . 0.0 111.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.49 -6.17 83.84 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.648 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.79 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 85.2 m -90.78 120.18 31.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.198 0.523 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -89.38 134.51 34.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.762 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.656 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 43.3 t -77.57 123.72 26.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.529 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -151.04 128.23 11.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.055 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 9.2 t-105 55.52 41.32 30.9 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.407 0.622 . . . . 0.0 109.892 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 57.99 29.42 17.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.814 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 45.7 mttm -141.4 144.94 34.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.4 m -89.87 121.32 31.88 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.249 0.547 . . . . 0.0 110.687 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 28' ' ' PRO . 71.8 p -127.98 166.05 19.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.155 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 98.9 mtt180 -127.7 121.8 31.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 t30 58.2 36.67 25.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.657 0.742 . . . . 0.0 110.316 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.14 16.61 75.19 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.085 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.9 tp -121.83 129.34 25.21 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.61 ' HA ' HG22 ' A' ' 23' ' ' THR . 10.8 Cg_exo -71.24 69.23 2.53 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.304 2.669 . . . . 0.0 112.655 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.547 -179.638 . . . . . . . . 0 0 . 1 stop_ save_